Original Research

Published on 04 Sep 2020

Anti-Contractile and Anti-Inflammatory Effects of Diacerein on Isolated Mouse Airways Smooth Muscle and Mouse Asthma Model

in Respiratory Pharmacology

Shunbo Shi
Lu Xue
Shuhui Han
Haiting Qiu
Yongbo Peng
Ping Zhao
Qing-Hua Liu
Jinhua Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.560361

3,414 views
6 citations

Review

Published on 27 Aug 2020

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019

in Respiratory Pharmacology

Chunsheng Zhu
Bao Sun
Xiaochuan Zhang
Bing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01327

8,265 views
4 citations

Original Research

Published on 19 Aug 2020

Pulmonary Deposition of Radionucleotide-Labeled Palivizumab: Proof-of-Concept Study

in Respiratory Pharmacology

Anushi E. Rajapaksa
Lien Anh Ha Do
Darren Suryawijaya Ong
Magdy Sourial
Duncan Veysey
Richard Beare
William Hughes
William Yang
Robert J. Bischof
Amarin McDonnell

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01291

3,796 views
9 citations

Original Research

Published on 30 Jul 2020

Anti-Bronchospasmodic Effect of JME-173, a Novel Mexiletine Analog Endowed With Highly Attenuated Anesthetic Activity

in Respiratory Pharmacology

Katharinne Ingrid Moraes Carvalho
Diego de Sá Coutinho
Humberto Cavalcante Joca
Artur Santos Miranda
Jader dos Santos Cruz
Emerson Teixeira Silva
Marcus Vinícius Nora Souza
Robson Xavier Faria
Patricia Machado Rodrigues e Silva
Jorge Carlos Santos Costa

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01159

2,471 views
2 citations

Mini Review

Published on 22 Jul 2020

Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis

in Respiratory Pharmacology

Viera Janosova
Vladimir Calkovsky
Heiko Pedan
Estera Behanova
Andrej Hajtman
Andrea Calkovska

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01135

4,243 views
10 citations

Original Research

Published on 21 Jul 2020

Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography

in Respiratory Pharmacology

Francesca Ruscitti
Francesca Ravanetti
Valeria Bertani
Luisa Ragionieri
Laura Mecozzi
Nicola Sverzellati
Mario Silva
Livia Ruffini
Valentina Menozzi
Maurizio Civelli

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01117

18,363 views
45 citations

Opinion

Published on 15 Jul 2020

The Post-Lockdown Era: What Is Next in Italy?

in Respiratory Pharmacology

Cristoforo Pomara
Giovanni Li Volti
Francesco Cappello

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01074

2,707 views
14 citations

Perspective

Published on 24 Jun 2020

Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy

in Respiratory Pharmacology

Ying Wang
Yang Zhang
Qian Yu
Kun Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00966

5,066 views
8 citations

Mini Review

Published on 24 Jun 2020

Pharmacotherapics Advice in Guidelines for COVID-19

in Respiratory Pharmacology

Zhang-Ren Chen
Ying Zhou
Jin Liu
Hong-Wei Peng
Jian Zhou
Hai-Li Zhong
Li-Li Liu
Ming-Fang Lai
Xiao-Hua Wei
Jin-Hua Wen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00950

8,431 views
6 citations

General Commentary

Published on 02 Jun 2020

Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519

in Respiratory Pharmacology

Harma Alma
Corina de Jong
Janwillem Kocks
Thys van der Molen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00827

1,880 views

Mini Review

Published on 26 May 2020

Reducing the Fatality Rate of COVID-19 by Applying Clinical Insights From Immuno-Oncology and Lung Transplantation

in Respiratory Pharmacology

Fatih M. Uckun

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00796

5,678 views
14 citations

Original Research

Published on 21 May 2020

Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension

in Respiratory Pharmacology

Ya-Ru Bao
Jing-Wei Chen
Yan Jiang
Lin-Hui Wang
Rong Xue
Jin-Xian Qian
Guo-Xing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00687

4,185 views
14 citations

Original Research

Published on 20 May 2020

Sinigrin Enhanced Antiasthmatic Effects of Beta Adrenergic Receptors Agonists by Regulating cAMP-Mediated Pathways

in Respiratory Pharmacology

Simeng Chu
Wenjuan Liu
Yujie Lu
Menglin Yan
Yingying Guo
Nianwei Chang
Min Jiang
Gang Bai

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00723

4,992 views
9 citations

Editorial

Published on 08 May 2020

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases

in Respiratory Pharmacology

Rui Zhang
Yang-Yang He
Zhi-Cheng Jing

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00660

2,510 views
2 citations

Review

Published on 06 May 2020

Respiratory Cilia as a Therapeutic Target of Phosphodiesterase Inhibitors

in Respiratory Pharmacology

Marta Joskova
Juraj Mokry
Sona Franova

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00609

11,406 views
25 citations

Original Research

Published on 06 May 2020

Inhibiting Airway Smooth Muscle Contraction Using Pitavastatin: A Role for the Mevalonate Pathway in Regulating Cytoskeletal Proteins

in Respiratory Pharmacology

Robin A. Lu
Amir A. Zeki
Sumati Ram-Mohan
Nhan Nguyen
Yan Bai
Kenneth Chmiel
Stevan Pecic
Xingbin Ai
Ramaswamy Krishnan
Chandra C. Ghosh

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00469

4,964 views
2 citations

Navigation group

Articles

Anti-Contractile and Anti-Inflammatory Effects of Diacerein on Isolated Mouse Airways Smooth Muscle and Mouse Asthma Model

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019

Pulmonary Deposition of Radionucleotide-Labeled Palivizumab: Proof-of-Concept Study

Anti-Bronchospasmodic Effect of JME-173, a Novel Mexiletine Analog Endowed With Highly Attenuated Anesthetic Activity

Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis

Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography

The Post-Lockdown Era: What Is Next in Italy?

Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy

Pharmacotherapics Advice in Guidelines for COVID-19

Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519

Reducing the Fatality Rate of COVID-19 by Applying Clinical Insights From Immuno-Oncology and Lung Transplantation

Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension

Sinigrin Enhanced Antiasthmatic Effects of Beta Adrenergic Receptors Agonists by Regulating cAMP-Mediated Pathways

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases

Respiratory Cilia as a Therapeutic Target of Phosphodiesterase Inhibitors

Inhibiting Airway Smooth Muscle Contraction Using Pitavastatin: A Role for the Mevalonate Pathway in Regulating Cytoskeletal Proteins